Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-25 @ 9:30 PM
Study NCT ID:
NCT05639751
Status:
COMPLETED
Last Update Posted:
2025-10-16
First Post:
2022-11-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation
Sponsor:
Prelude Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-11
First Submit QC Date:
None
Study First Post Date:
2022-12-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-14
Last Update Post Date:
2025-10-16
Last Update Post Date Type:
ESTIMATED